Become a KCNQ2 champion. For every dollar you contribute, we are one step closer to a CURE.
![Fundraiser_handbook_cover KCNQ2 fundraiser handbook](https://www.kcnq2cure.org/wp-content/uploads/2019/02/Fundraiser_handbook_cover.png)
KCNQ2 Cure's Fundraising Handbook
Be an active supporter in the quest to cure KCNQ2 Developmental and Epileptic Encephalopathy. Download our toolkit to launch your personal fundraising event.
Subscribe to the KCNQ2 Connections Newsletter
For news and updates on the latest KCNQ2 research, clinical trials, conferences, and family meet-ups.
KCNQ2 Connections
KCNQ2 Cure Alliance Awarded Chan Zuckerberg Initiative Rare As One Grant
Funding to Strengthen Organizational and Research Capacity to Accelerate Research for KCNQ2-Related Disorders We are thrilled to announce that the Chan Zuckerberg Initiative (CZI) has selected the foundation to receive a Rare As One Network grant. This award will be critical in accelerating operational efforts and supporting individuals and families impacted by KCNQ2-related disorders. “We are deeply…
KCNQ2-Related Epilepsy ICD-10 Codes Approved!
What is an ICD-10 Code? Developed by the World Health Organization (WHO), this is the tenth version of the International Classification of Diseases (ICD), known as ICD-10. It is a system used worldwide by doctors, hospitals, insurance companies, and health organizations to classify and code all diagnoses, symptoms, and procedures. Each code is unique and…
KCNQ2 Collaborations
![IMG_3767 IMG_3767](https://www.kcnq2cure.org/wp-content/uploads/2019/04/IMG_3767-e1556485977923-300x172.jpg)
Collaboration is key to efficiently advancing our mission to improve the lives of patients with KCNQ2 developmental and epileptic encephalopathy.
While KCNQ2 itself is a rare disease, it has many commonalities with other rare and not-so-rare disorders and manifests with symptoms – such as autism, sleep and mood disorders, and GI issues – that are seen quite commonly. We welcome discussions and partnerships with doctors, researchers, academic institutions, biopharmaceutical companies, and patient organizations, on a global basis, who share our passion for advancing treatments for patients with KCNQ2. If you are interested in opening the dialogue with KCNQ2 Cure Alliance, please contact Caroline Loewy.